Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma

NCT00900484

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • North Bay Cancer Center Fairfield, California, United States
View all 191 locations
View Trial Details
Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Piedmont Hospital Atlanta, Georgia, United States
  • Northside Hospital Cancer Center Atlanta, Georgia, United States
  • Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00357305

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +78 more
Locations
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

NCT00003425

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +74 more
Locations
  • Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions